A Clinical Trial for Accuracy of the new IV flow Regulator applied by the IV Flow Rate Calibrating Device

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0002637

Enrollment

250

Registered

2018-01-08

Start date

2018-01-22

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : Present IV therapy technology group use InnoFuser regulaor set producted by BD. New IV therapy technolongy group use New IV flow Regulator by the IV Flow Rate Calibrating Device produ

s order. New IV therapy regulator has drawing scale to adjust doctor&#39

s order and IV flow rate calibrating device to adjust doctor&#39

s order exactly. 1)1 Phase We will study of &#39

Infusion speed gap between New IV flow Regulator by the IV Flow Rate Calibrating Device and doctor&#39

s order will be under 10&#37

.&#39

(N=100, Present IV therapy technology group=50, New IV therapy technolongy group=50). Comparison fluid volume prescribed by physician with injected by clinical testing device. We will confirm accuracy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inpatients(Cardiovascular) and Outpatients(Rheumatology) who use IV therapy with IV Flow Regulator in eulji medical center.

Exclusion criteria

Exclusion criteria: 1)Less than 18 years 2)More than 80 years 3)LVEF<55% 4)Cr>2.0mg/dl 5)Hypernatremia patients 6)Patients who expect side effects ; IV therapy with 1L Normal saline for a day ; by researcher's judgment.

Design outcomes

Primary

Measure	Time frame
Accuracy comparison of New IV therapy technology group vs Present IV therapy technology group (Compare fluid water weight of before and after treatment)	—

Secondary

Measure	Time frame
Safety of New IV therapy technology group (Check fluid speed)	—

Countries

Korea, Republic of

Contacts

Public ContactSang Park

Eulji University

cardiopsh@gmail.com+82-42-611-3830

Outcome results